Life Technologies Corp. Research Report
Life Technologies recently announced the purchase of six Ion Torrent sequencers for its new Center for Personalized Medicine (CPM) at Roswell Park Cancer Institute (RPCI). Life Technologies President and COO Mark Stevenson notes that over 1000 organizations have adopted Ion Torrent technology in the past couple of years, giving the company more than 60 percent of the desktop sequencer market. These products will give researchers a simple workflow from discovery to validation. Life Technologies' recent purchase further strengthens its position in the Ion Torrent technology market, and analysts note that this is likely to drive the company forward, given the huge demand for Ion Torrent technology. The company's double-digit growth is also encouraging, along with its solid margins and solid cash flow. The Full Research Report on Life Technologies Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/cd9d_LIFE]
Laboratory Corp. of America Holdings Research Report
LabCorp recently announced that it is investing $2 million in SynapDx, an early stage laboratory services company, to further its development of an autism spectrum disorder test. This investment demonstrates LabCorp's commitment to the development of new and better approaches to ASD diagnosis. Recently, Laboratory Corp also reported net earnings of $120.2 million or $1.26 per share in the fourth quarter of 2012. It also announced a new share buyback pr
Copyright©2012 PR Newswire.
All rights reserved